Glenmark Pharmaceuticals to showcase new, updated data on GBR 830

10 May 2018 Evaluate

Glenmark Pharmaceuticals will be presenting new and updated data on GBR 830 at the upcoming International Investigative Dermatology (IID) meeting in Orlando, Florida.

The GBR 830 presentations at IID 2018 include one oral presentation and three poster presentations on GBR 830, an investigational treatment for moderate-to-severe atopic dermatitis. The IID meeting occurs only once every five years and brings together top researchers from across the globe to further the understanding of skin biology and dermatologic disease.

Glenmark Pharmaceuticals is a global innovative pharmaceutical company with operations in more than 50 countries.

Glenmark Pharma Share Price

1970.75 -25.15 (-1.26%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×